Upstream Bio, Inc. (UPB)

Upstream Bio Statistics

Total Valuation

Upstream Bio has a market cap or net worth of $1.18 billion. The enterprise value is $1.33 billion.

Market Cap	1.18B
Enterprise Value	1.33B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Upstream Bio has 51.34 million shares outstanding.

Shares Outstanding	51.34M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+1.09%
Owned by Insiders (%)	0.08%
Owned by Institutions (%)	21.69%
Float	28.75M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	29.48
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	597.00
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 23.72

Current Ratio	23.72
Quick Ratio	23.11
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	$58,447
Profits Per Employee	-$1.44M
Employee Count	38
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	1,417,479

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Upstream Bio had revenue of $2.22 million and -$54.81 million in losses. Loss per share was -$19.26.

Revenue	2.22M
Gross Profit	2.22M
Operating Income	-56.27M
Pretax Income	-54.81M
Net Income	-54.81M
EBITDA	-56.21M
EBIT	-56.27M
Loss Per Share	-$19.26

Balance Sheet

Cash & Cash Equivalents	235.80M
Total Debt	n/a
Net Cash	235.80M
Net Cash Per Share	$4.59
Equity (Book Value)	234.27M
Book Value Per Share	-50.91
Working Capital	232.79M

Cash Flow

Operating Cash Flow	-46.53M
Capital Expenditures	n/a
Free Cash Flow	-46.53M
FCF Per Share	-$0.91

Margins

Gross Margin	100.00%
Operating Margin	-2,533.50%
Pretax Margin	-1,823.82%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-2,094.87%

Dividends & Yields

Upstream Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-4.64%
FCF Yield	-3.94%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Upstream Bio has an Altman Z-Score of -0.49 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.49
Piotroski F-Score	1